Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 183

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Current Landscape of Targeted Therapy in Lung Cancer

Mayekar, Manasi K., Bivona, Trever G. · 2017 · Clinical Pharmacology & Therapeutics

Abstract

Lung cancer is the leading cause of cancer mortality worldwide. Comprehensive genomic profiling of lung cancers revealed their genetic heterogeneity and complexity and identified numerous targetable oncogenic driver alterations. These molecular profiling efforts have made it possible to exploit the potential of molecularly targeted therapies. Selection of patients for targeted therapies is becoming biomarker‐driven, where the oncogenic drivers in patient tumors are first identified, and subsequently patients bearing drug‐sensitizing genetic aberrations are matched to the appropriate targeted therapy. Success of this design of clinical trials and practice was first demonstrated in EGFR inhibitor trials in lung cancer and has since been incorporated into subsequent targeted therapy trials including ALK‐, ROS1‐, and BRAF V600E‐targeted therapies. In this review we discuss the current landscape of clinically approved and other promising molecularly targeted approaches for the treatment of lung cancers, the challenges with these approaches, and the strategies that could be deployed to overcome these challenges.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cpt.810

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 57

  1. 10.1016/j.phrs.2013.11.002 · DOI · Paper page
  2. 10.1634/theoncologist.8-4-303 · DOI · Paper page
  3. 10.1634/theoncologist.10-7-461 · DOI · Paper page
  4. 10.1200/JCO.2010.33.4235 · DOI · Paper page
  5. 10.1158/0008-5472.CAN-06-3339 · DOI · Paper page
  6. 10.1093/annonc/mdw611 · DOI · Paper page
  7. 10.1200/JCO.2017.35.18_suppl.LBA9007 · DOI
  8. Sullivan I., 2016, Next‐generation EGFR tyrosine kinase inhibitors for treating EGFR‐mutant lung cancer beyond first line, Front. Med. (Lausanne), 3, 76
  9. 10.1007/s40265-015-0533-4 · DOI · Paper page
  10. 10.1186/s13045-016-0290-1 · DOI · Paper page
  11. 10.1016/j.cell.2007.11.025 · DOI · Paper page
  12. 10.1002/cpt.653 · DOI
  13. 10.1016/S1470-2045(12)70344-3 · DOI · Paper page
  14. 10.1093/annonc/mdw305 · DOI · Paper page
  15. 10.1200/JCO.2017.35.15_suppl.LBA9008 · doi:10.1200/jco.2017.35.15_suppl.lba9008
  16. 10.1200/JCO.2016.71.5904 · DOI · Paper page
  17. 10.1056/NEJMoa1508887 · DOI · Paper page
  18. 10.1200/JCO.2017.35.15_suppl.9006 · DOI
  19. 10.1016/j.trecan.2016.05.010 · DOI · Paper page
  20. 10.1038/nm.3930 · DOI · Paper page
  21. 10.1634/theoncologist.2013-0095 · DOI · Paper page
  22. 10.1056/NEJMoa1215530 · DOI · Paper page
  23. 10.1073/pnas.1522052113 · DOI
  24. 10.1073/pnas.1515281112 · DOI
  25. 10.1158/1078-0432.CCR-14-1385 · DOI · Paper page
  26. 10.1073/pnas.1420785112 · DOI · Paper page
  27. 10.1158/2159-8290.CD-16-1237 · DOI · Paper page
  28. Sabari J.K., 2017, Targeting RET‐rearranged lung cancers with multikinase inhibitors, Oncoscience, 4, 23, 10.18632/oncoscience.345 · doi:10.18632/oncoscience.345
  29. 10.1200/JCO.2016.70.9352 · DOI · Paper page
  30. 10.1158/1078-0432.CCR-16-1887 · DOI
  31. 10.1517/13543784.2016.1152261 · DOI
  32. 10.1136/esmoopen-2015-000023 · DOI · Paper page
  33. 10.1038/nm.3352 · DOI · Paper page
  34. 10.1097/01.JTO.0000473485.38553.f0 · DOI · Paper page
  35. 10.1200/JCO.2017.35.15_suppl.LBA2501 · DOI
  36. 10.1158/2159-0000.CD-0000-0000 · doi:10.1158/2159-0000.cd-0000-0000
  37. 10.1177/1758834016670555 · DOI
  38. 10.1634/theoncologist.2016-0458 · DOI
  39. 10.1016/S1470-2045(16)30146-2 · DOI · Paper page
  40. 10.1073/pnas.1610456113 · DOI
  41. 10.1038/nature14982 · DOI · Paper page
  42. 10.1073/pnas.1320956111 · DOI
  43. 10.1016/j.ctrv.2014.02.008 · DOI · Paper page
  44. 10.1093/annonc/mdh031 · DOI · Paper page
  45. 10.1016/j.lungcan.2012.01.008 · DOI · Paper page
  46. 10.1016/j.jtho.2016.06.004 · DOI · Paper page
  47. 10.1158/2159-8290.CD-14-1467 · DOI · Paper page
  48. 10.1016/j.jtho.2016.10.014 · DOI · Paper page
  49. 10.1016/j.jtho.2016.06.013 · DOI · Paper page
  50. 10.1016/j.jtho.2016.09.119 · DOI
  51. 10.1016/j.jtho.2016.09.127 · DOI
  52. 10.1158/2159-8290.CD-16-0686 · DOI · Paper page
  53. 10.1002/cpt.552 · DOI
  54. 10.1177/1753465816670498 · DOI
  55. 10.1097/JTO.0000000000000113 · DOI
  56. 10.1016/j.celrep.2015.03.012 · DOI · Paper page
  57. 10.1016/S0140-6736(16)00004-0 · DOI · Paper page

Cited by

See all 183

Metadata

Authors
Mayekar, M. K., & Bivona, T. G.
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
2017-09-25
Volume
102
Issue
5
Pages
757-764
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W2743605523
Cited by
183
References
18
FWCI
14.98
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.